Compare BLCO & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | VFS |
|---|---|---|
| Founded | 1853 | 2017 |
| Country | Canada | Vietnam |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.3B |
| IPO Year | 2022 | 2022 |
| Metric | BLCO | VFS |
|---|---|---|
| Price | $17.41 | $3.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $19.39 | $6.07 |
| AVG Volume (30 Days) | ★ 485.4K | 423.2K |
| Earning Date | 10-28-2026 | 10-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $7.68 | $57.75 |
| Revenue Next Year | $5.95 | $43.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $14.44 | $2.78 |
| 52 Week High | $18.92 | $5.29 |
| Indicator | BLCO | VFS |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 49.00 |
| Support Level | $16.71 | $3.00 |
| Resistance Level | $17.54 | $3.27 |
| Average True Range (ATR) | 0.52 | 0.10 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 93.60 | 53.37 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.